Nurse Practitioner, Psychiatric/Mental Health · Lakewood, NJ
NPI
1992077630
Since 2012
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
23 Kedma Dr
Lakewood, NJ, 08701
Phone (732) 942-3464
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.1M
4,993 prescriptions
Company payments, 2025
$768
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Tzivya Kownat prescribed most often to Medicare patients was Benztropine Mesylate, with 277 prescriptions and refills. In total Tzivya Kownat wrote 4,993 Medicare prescriptions that cost $3.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Benztropine Mesylate Generic | 277 | 294 | 35 | $3,304 |
| Trazodone Hcl Generic | 229 | 245 | 40 | $2,188 |
| Clonazepam Generic | 223 | 223 | 25 | $1,306 |
| Risperidone Generic | 213 | 217 | 21 | $2,034 |
| Olanzapine Generic | 211 | 239 | 23 | $7,130 |
| Divalproex Sodium Generic | 171 | 171 | 19 | $6,467 |
| Haloperidol Generic | 166 | 168 | 17 | $5,095 |
| Divalproex Sodium Er Divalproex Sodium | 162 | 186 | 20 | $9,014 |
| Aripiprazole Generic | 160 | 166 | 21 | $9,898 |
| Invega Sustenna Paliperidone Palmitate | 155 | 160 | 21 | $536K |
| Quetiapine Fumarate Generic | 151 | 164 | 24 | $2,377 |
| Sertraline Hcl Generic | 147 | 152 | 22 | $1,500 |
| Gabapentin Generic | 143 | 149 | 20 | $1,461 |
| Lamotrigine Generic | 135 | 148 | 20 | $774 |
| Vivitrol Naltrexone Microspheres | 111 | 127 | 18 | $201K |
Brand drugs: - claims; generic drugs: 4,021 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tzivya Kownat $768 ($768 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $191.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $191 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $94.77 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $91.16 |
| Janssen Pharmaceuticals, Inc JNJ | 5 | $81.72 |
| Alkermes, Inc. ALKS | 3 | $46.86 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $34.7 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $30.04 |
| Boston Scientific Corporation BSX | 1 | $21.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.